132 results
8-K
EX-4.1
URGN
UroGen Pharma Ltd
18 Jun 24
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
5:07pm
. The Holder shall be responsible for all other tax liability that may arise as a result of holding or transferring this Warrant or receiving Warrant
8-K
EX-1.1
URGN
UroGen Pharma Ltd
18 Jun 24
UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants
5:07pm
aircraft chartered in connection with the road show, provided, however, that the Underwriters shall be responsible for the payment of fifty percent
424B5
URGN
UroGen Pharma Ltd
18 Jun 24
Prospectus supplement for primary offering
5:05pm
of ownership for an investor. We do not monitor and are not responsible for the actions of any of those intermediaries.
Special Situations When … supplement. When a global security terminates, the depositary, and neither we nor any applicable trustee, is responsible for deciding the names
424B5
URGN
UroGen Pharma Ltd
17 Jun 24
Prospectus supplement for primary offering
4:19pm
intermediary in the chain of ownership for an investor. We do not monitor and are not responsible for the actions of any of those intermediaries … covered by the prospectus supplement. When a global security terminates, the depositary, and neither we nor any applicable trustee, is responsible
8-K
fozb1kikwyxg1 nxyf8w
17 Jan 24
Entry into a Material Definitive Agreement
4:16pm
UPLOAD
qlh9bb78i0
5 Dec 23
Letter from SEC
12:00am
UPLOAD
wnmgp4t
16 Nov 23
Letter from SEC
12:00am